ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995

Nurses Must Assist In Pain Management, ONS Says

May 31, 1991

House Committee Investigates ESA Safety, Urges Amgen, J&J, To Stop Promotions.

March 23, 2007

Coffee, Soft Drinks Have Little Association With Colon Cancer

May 28, 2010

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

January 13, 1995

Device Maker Threatens Legal Action Against Doctor Who Launched Campaign to End Power Morcellation

September 5, 2014